Morel Sara B A, Macias Luis H, Chopra Ritu, Vorstenbosch Joshua, Safran Tyler
Aesthet Surg J. 2025 Aug 18;45(9):869-874. doi: 10.1093/asj/sjaf096.
Achieving optimal neck contour during facial rejuvenation may require addressing the submandibular glands, as supraplatysmal fat removal alone is insufficient for many patients, particularly those with fuller necks. The purpose of this study is to review the rate of complications associated with removal and techniques to improve safety. A comprehensive search was conducted to identify literature on complications associated with submandibular gland removal in the context of facial rejuvenation. Studies were included if they provided patient data and complication rates following surgical outcomes. Screening of 908 articles identified 11 (1.21%) studies on complication rates related to submandibular gland resection for aesthetic purposes. A total of 3379 participants were included, of which 48.86% (n = 1651) underwent submandibular gland resection, with a mean age of 50.4 years (range, 32-83), and 88.53% (n = 247) were female. Complications included hematomas (1.15%, n = 16), requiring reoperation in 23.08% (n = 3) of cases, sialoceles (1.33%, n = 21), salivary fistulas (0.82%, n = 6), nerve injury (3.97%, n = 40), xerostomia (0.13%, n = 1), and neck induration (21.43%, n = 21), with complication rates varying across studies. Submandibular gland reduction offers aesthetic benefits but comes with potential risks. Effective preoperative planning, meticulous gland mobilization, and proper exposure are essential for minimizing risks. Advances in techniques, such as improved dissection methods, the use of botulinum toxin, netting techniques, and energy-based instruments like LigaSure (Medtronic, Minneapolis, MN), have enhanced the safety of the procedure. While complications can arise, they typically resolve within a few months, and the overall outcomes improve with surgical experience. The associated risks and benefit profile should be discussed thoroughly with patients. Level of Evidence: 3 (Therapeutic).